Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | H538Q |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | JAK2 H538Q does not lie within any known functional domains of the Jak2 protein (UniProt.org). H538Q results in increased proliferation, Jak2 phosphorylation, and downstream Stat5 phosphorylation in combination with K539L in culture (PMID: 22584586, PMID: 17267906), but has not been individually characterized and therefore, its effect on Jak2 protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
JAK2 mutant JAK2 exon12 JAK2 H538Q |
Transcript | NM_004972.4 |
gDNA | chr9:g.5070025C>A |
cDNA | c.1614C>A |
Protein | p.H538Q |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001322195.1 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_001322196.1 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_004972.3 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_001322194.1 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_001322194.2 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_001322195 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_001322196 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.5070025C>A | c.1614C>A | p.H538Q | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
JAK2 exon12 | polycythemia vera | not applicable | N/A | Guideline | Diagnostic | JAK2 exon 12 mutations aid in the diagnosis of polycythemia vera (NCCN.org). | detail... |
JAK2 mutant | essential thrombocythemia | not applicable | N/A | Guideline | Diagnostic | JAK2 mutations aid in the diagnosis of essential thrombocythemia (NCCN.org). | detail... |
JAK2 mutant | B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK2 mutations are associated with a poor prognosis in patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |
JAK2 mutant | childhood B-cell acute lymphoblastic leukemia | not applicable | N/A | Guideline | Prognostic | JAK2 mutations are associated with a poor prognosis in pediatric patients with B-cell acute lymphoblastic leukemia (NCCN.org). | detail... |
JAK2 mutant | myelofibrosis | not applicable | N/A | Guideline | Diagnostic | JAK2 mutations aid in the diagnosis of primary myelofibrosis (NCCN.org). | detail... |